Edition:
United States

Aclaris Therapeutics Inc (ACRS.OQ)

ACRS.OQ on NASDAQ Stock Exchange Global Select Market

24.72USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$24.72
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
110,325
52-wk High
$33.21
52-wk Low
$21.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.68 -0.631
Jun '17 0.00 -0.558
Mar '17 0.00 -0.482
FY 2016 Dec '16 0.00 -0.491
Sep '16 0.00 -0.499
Jun '16 0.00 -0.623
Mar '16 0.00 -0.646
FY 2015 Dec '15 0.00 -0.244
Sep '15 0.00 -0.577
Jun '15 0.00 -1.517
Mar '15 0.00 -1.612
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 0.65 1.00 0.00 0.00
Quarter Ending Mar-18 1 1.00 1.00 1.00 --
Year Ending Dec-17 5 1.22 1.70 0.70 0.00
Year Ending Dec-18 5 28.53 43.00 18.58 68.64
Earnings (per share)
Quarter Ending Dec-17 5 -0.91 -0.84 -1.04 -1.04
Quarter Ending Mar-18 1 -1.73 -1.73 -1.73 --
Year Ending Dec-17 4 -2.59 -2.51 -2.65 -3.03
Year Ending Dec-18 5 -3.83 -2.11 -4.83 -1.90
LT Growth Rate (%) 1 66.00 66.00 66.00 72.40
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 196.13 36.03
P/E High - Last 5 Yrs. -- 279.92 45.26
P/E Low - Last 5 Yrs. -- 93.48 24.26
Beta -- 0.82 0.91
Price to Sales (TTM) 1,084.08 117.54 5.90
Price to Book (MRQ) 3.12 23.08 5.74
Price to Tangible Book (MRQ) 3.40 26.92 7.33
Price to Cash Flow (TTM) -- 106.51 24.72
% Owned Institutions 96.04 5.59 1.38

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.48
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.02 5.23
Payout Ratio(TTM) -- 98.85 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -4.33 6.77
Sales (TTM) vs TTM 1 Yr. Ago -- 30.49 5.56
Sales - 5 Yr. Growth Rate -- 33.28 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago -26.34 -148.85 7.88
EPS (TTM) vs TTM 1 Yr. Ago -7.34 -- --
EPS - 5 Yr. Growth Rate -- 44.44 10.92
Capital Spending - 5 Yr. Growth Rate -- 41.25 15.15

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.55
Current Ratio (MRQ) 23.43 5.63 3.57
LT Debt to Equity (MRQ) 0.00 16.33 13.26
Total Debt to Equity (MRQ) 0.00 18.85 19.22
Interest Coverage (TTM) -- -144.78 43.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 33.77 43.82 54.87
Gross Margin - 5 Yr. Avg. -- 55.59 52.44
EBITD Margin (TTM) -8,530.26 -- --
EBITD - 5 Yr. Avg -- -215.54 15.70
Operating Margin (TTM) -8,568.42 -635.70 6.77
Operating Margin - 5 Yr. Avg. -- -232.57 11.08
Pre-Tax Margin (TTM) -8,342.69 -605.50 7.60
Pre-Tax Margin - 5 Yr. Avg. -- -232.71 11.49
Net Profit Margin (TTM) -8,342.69 -603.22 3.83
Net Profit Margin - 5 Yr. Avg. -- -236.06 7.78
Effective Tax Rate (TTM) -- 15.54 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.17 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 22,065 22,216,302 857,902,259
Net Income/Employee (TTM) -1,840,774 -2,116,531 100,310,105
Receivable Turnover (TTM) -- 26.19 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.00 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -32.85 -9.39 11.35
Return on Assets - 5 Yr. Avg. -- 0.13 12.32
Return on Investment (TTM) -34.29 -11.69 14.48
Return on Investment - 5 Yr. Avg. -- 3.37 16.13
Return on Equity (TTM) -35.08 -36.44 16.06
Return on Equity - 5 Yr. Avg. -- 5.73 17.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -95.66 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aclaris Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 8.95 6.22 75 96
13 Week -6.51 -12.02 42 74
26 Week 0.57 -7.76 58 59
52 Week -13.26 -26.30 40 62
YTD -8.92 -23.11 45 52
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 92.24%
# of Holders: 156
Total Shares Held: 27,669,386
3 Mo. Net Change: 1,739,885
# New Positions: 15
# Closed Positions: 13
# Increased Positions: 87
# Reduced Positions: 44
# Net Buyers: 43
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.